shutterstock_742803874

Biosimilars: use and substitution

Biopharmaceuticals with the same active ingredient but from different manufacturers cannot be substituted for one another in pharmacies. This is set to change, according to the law.

However, there are many reasons why the decision should remain with the medical profession. Read on to find out why this is the case and what consequences the planned substitution in pharmacies may have.

 

Why doctors should decide over the use of biosimilars

Complex application, professional consultation, impending nocebo effect: Patients who take a biosimilar require doctor’s advice and medical consultation

Read more
getty images/1224302166

Why automatic substitution is not needed

Little benefit, high risks: greater savings with biosimilars can only be achieved at the expense of supply security.

Read more